FDA Inspection 1173950 — Anne Hurlet, M.D.

Anne Hurlet, M.D. — FEI 3021601146

The FDA completed an inspection of Anne Hurlet, M.D. on June 10, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)